Lyra Therapeutics/LYRA
$0.39
-0.46%About Lyra Therapeutics
Ticker
Sector
Trading on
Industry
CEO
Employees
Headquarters
LYRA Metrics
$24M
-
-$1.23
0.16
-
Price and volume
Financial strength
Management effectiveness
Valuation
Growth
What the Analysts think about LYRA
Analyst Ratings
Price Targets
$0.39
$0.95
LYRA Financial Performance
Income Statement
Q1 24
QoQ growth
$500K
400%
-$22M
48.34%
-4,480%
-70.33%
LYRA Earnings Performance
Earnings per share (EPS)
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
-$0.36
-$0.27
-$0.22
-$0.35
-
-$0.42
-$0.32
-$0.32
-$0.26
-$0.33
-14.96%
-15.09%
-30.16%
33.59%
-
Upcoming events
FAQs
What’s the current market cap for Lyra Therapeutics stock?
What is the P/E ratio for Lyra Therapeutics stock?
Does Lyra Therapeutics stock pay dividends?
No, Lyra Therapeutics (LYRA) stock does not pay dividends to its shareholders as of May 11, 2024.
When is the next Lyra Therapeutics dividend payment date?
Lyra Therapeutics (LYRA) stock does not pay dividends to its shareholders.
What is the beta indicator for Lyra Therapeutics?
Lyra Therapeutics (LYRA) has a beta rating of 0.12. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
What is the Lyra Therapeutics stock price target?
The target price for Lyra Therapeutics (LYRA) stock is $0.95, which is 156.76% above the current price of $0.37. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.